Identification of Tamoxifen-Resistant Breast Cancer Cell Lines and Drug Response Signature

Lignende værker

• A Qualitative Transcriptional Signature for Predicting Extreme Resistance of ER-Negative Breast Cancer to Paclitaxel, Doxorubicin, and Cyclophosphamide Neoadjuvant Chemotherapy
  af: Chen, Yanhua, et al.
  Udgivet: (2020)
• ERα36 as a Potential Therapeutic Target for Tamoxifen-Resistant Breast Cancer Cell Line Through EGFR/ERK Signaling Pathway
  af: Li, Guangliang, et al.
  Udgivet: (2020)
• Influence of MiR-451 on Drug Resistances of Paclitaxel-Resistant Breast Cancer Cell Line
  af: Gu, Xi, et al.
  Udgivet: (2015)
• Tamoxifen therapy benefit predictive signature coupled with prognostic signature of post-operative recurrent risk for early stage ER+ breast cancer
  af: Cai, Hao, et al.
  Udgivet: (2015)
• Tamoxifen resistance and epigenetic modifications in breast cancer cell lines
  af: Badia, Eric, et al.
  Udgivet: (2007)